Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Allison M. Weisnicht
Observed name:
Allison Weisnicht
Institutions:
University of Wisconsin–Madison,
University of Wisconsin Carbone Cancer Center
Observed institutions:
University of Wisconsin–Madison,
Baylor College of Medicine,
University of Wisconsin Carbone Cancer Center,
University of Wisconsin American Family Children's Hospital
ORCID:
0009-0000-6861-3012
Observed ORCID:
0009-0000-6861-3012
OpenAlex ID:
A5036855913
Impact of Anaerobiosis on Expression of the Iron-Responsive Fur and RyhB Regulons
2015
·
Nicole A. Beauchene
, Kevin S. Myers
, et al.
·
mBio
·
70
Repurposing Atovaquone as a Therapeutic against Acute Myeloid Leukemia (AML): Combination with Conventional Chemotherapy Is Feasible and Well Tolerated
2023
·
Alexandra McLean Stevens
, Eric S. Schafer
, et al.
·
Cancers
·
17
PDF
What Is the Expected Clearance of Methotrexate? A Therapeutic Drug Monitoring Reference Guide for High‐Dose Methotrexate Use in Pediatric Malignancies
2025
·
Zachary L. Taylor
, Tamara P. Miller
, et al.
·
Pediatric Blood & Cancer
·
5
PDF
Influence of albumin and methotrexate clearance on high-dose methotrexate-induced mucositis.
2022
·
Zachary L. Taylor
, Tamara P. Miller
, et al.
·
Journal of Clinical Oncology
·
2
Comparison of Severe Toxicities Following High Dose Methotrexate Administration By Demographics and over Time in Pediatric Patients with Acute Lymphoblastic Leukemia
2021
·
Tamara P. Miller
, Nicholas P. DeGroote
, et al.
·
Blood
·
2
Severe Adverse Events Associated with Concentrations of High Dose Methotrexate in Pediatric Acute Lymphoblastic Leukemia Patients
2022
·
Tamara P. Miller
, Nicholas P. DeGroote
, et al.
·
Blood
·
1
Recurrent Rash in an 11-Year-Old Boy With Pericardial and Pleural Effusions
2022
·
Allison M. Weisnicht
, Ryan Byrne
, et al.
·
PEDIATRICS
·
1
Route of Nutrition Impacts Outcomes After Autologous Stem Cell Transplant for High‐Risk Neuroblastoma
2026
·
Caleb Kitcho
, David Bergstrand
, et al.
·
Pediatric Blood & Cancer
Safety and Feasibility of Infusing Ex Vivo Expanded Allogeneic Canine Natural Killer Cells for the Treatment of Metastatic Solid Tumours
2026
·
Allison M. Weisnicht
, Fernanda Szewc
, et al.
·
Veterinary and Comparative Oncology
Follicular Dendritic Cell Sarcoma in an Adolescent Patient
2026
·
Hannah Glanz
, Allison Weisnicht
, et al.
·
Journal of Pediatric Hematology/Oncology
Safety and Feasibility of Infusing Ex Vivo Expanded Allogeneic Canine Natural Killer Cells for the Treatment of Metastatic Solid Tumors
2026
·
Allison M. Weisnicht
, Fernanda Szewc
, et al.
·
bioRxiv (Cold Spring Harbor Laboratory)
PDF
From famine to feast: a seesawing platelet count in severe iron deficiency anemia
2025
·
Allison Weisnicht
, Eduard Matkovic
·
Journal of Hematopathology
PDF
Optimal therapy for pediatric B-ALL in first relapse: Comparative effectiveness of blinatumomab to hematopoietic cell transplantation versus CD19 CAR T cell therapy
2025
·
Regina Myers
, Yimei Li
, et al.
·
Blood
Disparate post-relapse survival outcomes by race/ethnicity for children with B-cell acute lymphoblastic leukemia: An analysis from the recall-1 study
2025
·
Abigale Berry
, Caitlin Elgarten
, et al.
·
Blood
Survival after first relapse of pediatric B-ALL differs by insurance type: A real-world analysis from the recall-1 study
2025
·
Katherine Lind
, Abigale Berry
, et al.
·
Blood
PDF
348 Ex vivo expansion and activation of canine allogeneic natural killer cells for therapeutic use against metastatic solid tumors
2025
·
Allison Weisnicht
, Fernanda Szwec
, et al.
·
Regular and Young Investigator Award Abstracts
PDF
Path-38. Intracranial Sarcoma With Dicer1 Mutation in a Patient With Neurofibromatosis Type 1
2024
·
Allison Weisnicht
, Nicholas Pytel
·
Neuro-Oncology
PDF
Child presenting with unilateral vision loss
2024
·
Allison Weisnicht
, Eric Monroe
·
Journal of the American College of Emergency Physicians Open
PDF
CPX-351 associated rash in pediatric patients with acute myeloid leukemia: a case series
2024
·
Allison Weisnicht
, Audrey Chan
, et al.
PDF
Combining Atovaquone with Intensive Conventional Chemotherapy for Pediatric Acute Myeloid Leukemia (AML) Is Feasible and Well Tolerated
2021
·
Alexandra McLean Stevens
, Eric Schafer
, et al.
·
Blood
Show more works
View as search
Works count:
20
Citation count:
98
H-index:
3
I10-index:
2
Year
Topic
Type